HC Wainwright Weighs in on Acurx Pharmaceuticals, Inc.’s FY2028 Earnings (NASDAQ:ACXP)
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP – Free Report) – HC Wainwright issued their FY2028 earnings estimates for shares of Acurx Pharmaceuticals in a report issued on Tuesday, March 19th. HC Wainwright analyst E. Arce expects that the company will post earnings per share of ($4.13) for the year. HC Wainwright has a “Buy” rating and a […]
More Stories
Artemis II Mission Ends With Splashdown Off San Diego
By T.J. Muscaro HOUSTON—Humanity’s first adventure to the moon in more than 50 years is complete. Artemis II, NASA’s 10-day...
Trump Warns Iran Has ‘No Cards’ Except Strait of Hormuz in Peace Talks
By Jack Phillips President Donald Trump on Friday said that the Iranian regime has very few negotiating options ahead of...
State Department Settles Lawsuit Alleging It Censored Conservative Outlets Under Biden
By Jacki Thrapp The Department of Justice (DOJ) settled a lawsuit that accused the Biden administration of censoring speech by...
Supreme Court Upholds Reversal of Death Declaration in Case of Man Found to Be Alive
By The Canadian Press The Supreme Court of Canada has affirmed a judge’s decision to annul the declaration of a...
US Annual Inflation Shoots Up to 3.3 Percent, Highest Level Since May 2024
By Andrew Moran A spike in energy prices sent the annual U.S. inflation rate to its highest level since May...
Iran Declares Strait of Hormuz Open, but Warns of Risk From Mines
By Chris Summers Iran said on April 9 that the Strait of Hormuz is open to all civilian shipping but...